Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Chung

Showing results (111-120 of 237) with videos related to

Pageof 24
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 26, 2011
The effect of delineation method and observer variability on bladder dose-volume histograms for prostate intensity modulated radiotherapyTara Rosewall, Andrew J Bayley, Peter Chung, et al.
The Journal of Urology|April 1, 2015
Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell TumorsMadhur Nayan, Michael A S Jewett, Joan Sweet, et al.
Radiation Oncology (London, England)|November 6, 2009
Image guided dose escalated prostate radiotherapy: still room to improveJarad M Martin, Andrew Bayley, Robert Bristow, et al.
The Journal of Biological Chemistry|April 30, 2003
Interaction of activator of G-protein signaling 3 (AGS3) with LKB1, a serine/threonine kinase involved in cell polarity and cell cycle progression: phosphorylation of the G-protein regulatory (GPR) motif as a regulatory mechanism for the interaction of GPR motifs with Gi alphaJoe B Blumer, Michael L Bernard, Yuri K Peterson, et al.
Brachytherapy|May 22, 2019
Dose to the bladder neck in MRI-guided high-dose-rate prostate brachytherapy: Impact on acute urinary toxicity and health-related quality of lifeNoelia Sanmamed, Peter Chung, Alejandro Berlin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 20, 2020
Current topics in radiotherapy for genitourinary cancers: Consensus statements of the Genitourinary Radiation Oncologists of CanadaScott C Morgan, Gerard C Morton, Alejandro Berlin, et al.
Cancer Research|July 10, 2007
Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation responseMichael Milosevic, Peter Chung, Chris Parker, et al.
International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapyDanny Vesprini, Michael Sia, Gina Lockwood, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 23, 2021
Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Markov microsimulation modelDiana Magee, Douglas Cheung, Amanda Hird, et al.
Journal of Applied Clinical Medical Physics|January 14, 2026
Evaluation of hybrid DIR performance using controlling structures and points of interest in MR-guided adaptive radiotherapy for prostate cancer patientsVictor Malkov, Iymad R Mansour, Vickie Kong, et al.
Pageof 24

Showing results (111-120 of 237) with videos related to

Sort By:
Pageof 24
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 26, 2011
The effect of delineation method and observer variability on bladder dose-volume histograms for prostate intensity modulated radiotherapyTara Rosewall, Andrew J Bayley, Peter Chung, et al.
The Journal of Urology|April 1, 2015
Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell TumorsMadhur Nayan, Michael A S Jewett, Joan Sweet, et al.
Radiation Oncology (London, England)|November 6, 2009
Image guided dose escalated prostate radiotherapy: still room to improveJarad M Martin, Andrew Bayley, Robert Bristow, et al.
The Journal of Biological Chemistry|April 30, 2003
Interaction of activator of G-protein signaling 3 (AGS3) with LKB1, a serine/threonine kinase involved in cell polarity and cell cycle progression: phosphorylation of the G-protein regulatory (GPR) motif as a regulatory mechanism for the interaction of GPR motifs with Gi alphaJoe B Blumer, Michael L Bernard, Yuri K Peterson, et al.
Brachytherapy|May 22, 2019
Dose to the bladder neck in MRI-guided high-dose-rate prostate brachytherapy: Impact on acute urinary toxicity and health-related quality of lifeNoelia Sanmamed, Peter Chung, Alejandro Berlin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 20, 2020
Current topics in radiotherapy for genitourinary cancers: Consensus statements of the Genitourinary Radiation Oncologists of CanadaScott C Morgan, Gerard C Morton, Alejandro Berlin, et al.
Cancer Research|July 10, 2007
Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation responseMichael Milosevic, Peter Chung, Chris Parker, et al.
International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapyDanny Vesprini, Michael Sia, Gina Lockwood, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 23, 2021
Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Markov microsimulation modelDiana Magee, Douglas Cheung, Amanda Hird, et al.
Journal of Applied Clinical Medical Physics|January 14, 2026
Evaluation of hybrid DIR performance using controlling structures and points of interest in MR-guided adaptive radiotherapy for prostate cancer patientsVictor Malkov, Iymad R Mansour, Vickie Kong, et al.
Pageof 24